GHK-Cu peptide claims on TikTok: what the research actually supports

What did @srpeptido actually say?

Honestly, this is a tough one to fact-check. The transcript provided for this video is garbled beyond useful interpretation, likely the result of a failed auto-transcription of Spanish audio. The caption, however, does make specific claims: GHK-Cu is described as a small copper-bound peptide, also called copper tripeptide-1, that participates in "tissue repair processes, cellular signaling, and skin care." The creator also solicits direct messages, which is a common pattern on peptide-promotion accounts.

Because the spoken content is unverifiable from this transcript, this fact-check focuses on the caption's claims and the general framing of GHK-Cu as a peptide with preclinical evidence behind it. That framing is, at minimum, defensible. Whether the DM-based sales pitch holds up to the same standard is a separate question.

Does the science back this up?

To a meaningful degree, yes, but with real caveats about what stage the evidence is at. GHK-Cu is an endogenous tripeptide, meaning your body already makes it. Concentrations decline with age, which is part of why researchers got interested in it in the first place. The compound has been studied since the 1970s, when Loren Pickart first identified it in human plasma.

On tissue repair, there is legitimate preclinical data. Pickart and Margolina (2018, Cosmetics) reviewed decades of research showing GHK-Cu promotes collagen and glycosaminoglycan synthesis in vitro. A study by Gorouhi and Maibach (2009, Skin Pharmacology and Physiology) found topical copper peptides improved wound healing metrics in animal models. On cellular signaling, GHK-Cu has been shown to modulate gene expression, with Pickart et al. estimating it affects over 4,000 genes in a 2012 analysis published in Biochemistry Insights. These are real findings. They are also mostly preclinical, and human clinical trial data remains thin.

What did they get wrong (or right)?

The caption gets the basic biology right. GHK-Cu is genuinely studied for tissue repair and cellular signaling, and framing those as "possible benefits according to preclinical studies" is actually more honest than most peptide content on TikTok. Credit where it is due: the creator did not appear to claim it cures a disease, at least not in the caption.

What raises concern is the structure of the post itself. Directing viewers to a DM to learn more about a peptide with no disclosed regulatory status, no mention of the difference between cosmetic topical formulations and injectable peptides, and no warning about sourcing risks is a real problem. Injectable GHK-Cu exists in compounded form and is not FDA-approved as a drug. Topical copper peptides are a different category entirely. Mixing those two things without clarity is how patients end up confused about what they are actually buying or injecting.

What should you actually know?

GHK-Cu is one of the more credible peptides in this space from a basic science standpoint, but that does not mean it is ready for prime time as an injectable therapy. Here is what the evidence actually supports right now.

• Topical GHK-Cu has the strongest human evidence base, primarily in dermatology and wound care contexts.
• Injectable GHK-Cu is compounded, not FDA-approved, and clinical safety data in humans is limited.
• Gene expression studies are interesting but do not translate directly into clinical outcomes for patients.
• No dose has been established as safe and effective in human trials for systemic use.
• Sourcing matters enormously. Compounded peptides vary in purity and concentration depending on the pharmacy and oversight level.

If you are curious about GHK-Cu, talk to a licensed clinician who can review your individual situation, not someone selling via DM on TikTok.